Oncogenic mutant KRAS inhibition through oxidation at cysteine 118.
Kramer-Drauberg M, Petrini E, Mira A, Patrucco E, Scardaci R, Savinelli I, Wang H, Qiao K, Carrà G, Nokin MJ, Zhou Z, Westover KD, Santamaria D, Porporato PE, Ambrogio C.
Kramer-Drauberg M, et al. Among authors: qiao k.
Mol Oncol. 2025 Jan 21. doi: 10.1002/1878-0261.13798. Online ahead of print.
Mol Oncol. 2025.
PMID: 39838816